Does BORTEZOMIB Cause Malignant transformation? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Malignant transformation have been filed in association with BORTEZOMIB (bortezomib). This represents 0.0% of all adverse event reports for BORTEZOMIB.
12
Reports of Malignant transformation with BORTEZOMIB
0.0%
of all BORTEZOMIB reports
10
Deaths
0
Hospitalizations
How Dangerous Is Malignant transformation From BORTEZOMIB?
Of the 12 reports, 10 (83.3%) resulted in death.
Is Malignant transformation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Malignant transformation?
OSIMERTINIB (109)
ETOPOSIDE (108)
MELPHALAN (95)
CYTARABINE (91)
CARMUSTINE (88)
CYCLOPHOSPHAMIDE (73)
PREDNISONE (69)
GEFITINIB (67)
VINCRISTINE (66)
DOXORUBICIN (61)
Which BORTEZOMIB Alternatives Have Lower Malignant transformation Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX